Ekol Hospitals: Transforming Obesity Treatment with Innovation, Compassion, and a Balanced Approach

Ekol Hospitals leads in shaping the future of Obesity Treatment

Ekol International Hospitals, a leading authority in obesity treatment in Türkiye, underscores the urgent need for a holistic and personalised approach to obesity management, calling for global action by integrating medical innovation, lifestyle changes, and societal education to create sustainable solutions for this global health challenge.

LONDON, UNITED KINGDOM / ACCESSWIRE / January 7, 2025 / The global conversation around obesity has been reignited with the UK’s recent approval of Mounjaro (tirzepatide) for weight management under the National Health Service (NHS). Ekol International Hospitals, a leading authority in obesity treatment, calls for a more nuanced approach to this complex condition – recognising the potential benefits of newly approved medications while carefully considering their possible side effects, and emphasizing the continued importance of comprehensive, patient-centred care strategies, including bariatric surgery.

Embracing Medical Advancements Responsibly

Pharmacological breakthroughs like Mounjaro (tirzepatide) represent significant progress in the medical management of obesity; however, experts at Ekol caution that no single medication can fully address such a multifaceted health issue. It is essential to acknowledge potential side effects associated with any medication and to understand that pharmacotherapy must be carefully tailored to each patient’s medical history and overall condition.

“Obesity is not merely a number on a scale; it’s a chronic condition influenced by biology, behaviour, and socio-environmental factors,” said Prof. Dr. Ömer Yoldaş, a bariatric surgery specialist at Ekol International Hospitals.

“While the approval of Mounjaro is a promising development, its success – and the safety of patients – depends on incorporating this medication into a well-rounded treatment plan that also addresses potential side effects. Addressing obesity requires more than just a drug; it demands an integrative and comprehensive approach.”

The Role of Bariatric Surgery and a Tailored Approach

Recognising that medication alone may not suffice for many patients, Ekol International Hospitals has pioneered a multidisciplinary model for treating obesity. This model combines advanced medical therapies, bariatric surgery, psychological support, and nutritional counselling. Bariatric surgery – such as sleeve gastrectomy or gastric bypass – remains an effective option for individuals struggling with severe obesity and related health complications. These procedures can provide significant long-term weight loss and health benefits when combined with lifestyle modifications and ongoing support.

“Every individual has a unique story when it comes to obesity, and one treatment does not fit all,” added Prof. Dr. Yoldaş.

“For some patients, the benefits of bariatric surgery can be life-changing, especially when medication alone is insufficient or not suitable. Our approach prioritises understanding the patient as a whole – both their medical needs and personal circumstances – ensuring a more effective and lasting outcome.”

Addressing the Wider Impact of Obesity

Obesity’s impact goes beyond physical health, with strong links to mental health challenges such as depression and anxiety, a diminished quality of life, and societal stigma. Ekol International Hospitals emphasises that addressing these interconnected factors is essential to achieving meaningful and sustained results.

“The stigma around obesity often prevents individuals from seeking help, leading to a cycle of isolation and worsening health,” noted Prof. Dr. Ömer Yoldaş.

“At Ekol Hospitals, we provide a safe and supportive environment where patients feel understood and empowered. By offering medical and surgical options alongside psychological and nutritional support, we can more effectively help individuals regain control of their health.”

Ekol International Hospitals calls on the global healthcare community to treat obesity as a multidimensional challenge, requiring unified efforts and a patient-specific approach. By combining innovative medical treatments – including newer medications like Mounjaro – alongside surgical interventions, lifestyle support, and educational initiatives, a truly impactful and long-lasting reduction in obesity rates can be achieved.

Uniting Global Efforts Through Innovation and Compassion

“The fight against obesity is not just about medicine; it’s about empowering individuals and communities to make informed and sustainable lifestyle choices,” explained Prof. Dr. Yoldaş.

“A comprehensive strategy must integrate innovation with compassion. Our goal is to ensure every patient, and society as a whole, can benefit from meaningful change – whether through medical therapies, bariatric surgery, or both.”

About Ekol International Hospitals

Founded in 2007 in Izmir, Turkey, Ekol International Hospitals is a globally recognised healthcare institution committed to excellence in patient care. With a focus on cutting-edge technology and multidisciplinary expertise, Ekol Hospital provides personalised treatment plans across a range of medical specialities, including obesity management. The dedicated team at Ekol prides itself on offering a holistic approach – combining medical, surgical, and supportive therapies – to help patients achieve long-term health and well-being.

Business Name: FL PR & Communications
Web Site: https://flcommunications.co.uk
Contact: Furkan Luleci
E-mail address: asset@flcommunications.co.uk
+905330202554

SOURCE: Ekol International Hospitals

View the original press release on accesswire.com